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Abstract
Background: Several forms of progressive retinal atrophy (PRA) segregate in more than 100
breeds of dog with each PRA segregating in one or a few breeds. This breed specificity may be
accounted for by founder effects and genetic drift, which have reduced the genetic heterogeneity
of each breed, thereby facilitating the identification of causal mutations. We report here a new form
of PRA segregating in the Border Collie breed. The clinical signs, including the loss of night vision
and a progressive loss of day vision, resulting in complete blindness, occur at the age of three to
four years and may be detected earlier through systematic ocular fundus examination and
electroretinography (ERG).
Results: Ophthalmic examinations performed on 487 dogs showed that affected dogs present a
classical form of PRA. Of those, 274 have been sampled for DNA extraction and 87 could be
connected through a large pedigree. Segregation analysis suggested an X-linked mode of
transmission; therefore both XLPRA1 and XLPRA2 mutations were excluded through the genetic
tests.
Conclusion: Having excluded these mutations, we suggest that this PRA segregating in Border
Collie is a new XLPRA (XLPRA3) and propose it as a potential model for the homologous human
disease, X-Linked Retinitis Pigmentosa.
Background
Progressive Retinal Atrophy (PRA) has been described in
more than 100 breeds of dog [1-3], providing a powerful
resource for the identification of new retinopathy-causing
genes and a unique model for treatments for homologous
human retinal diseases [4,5]. The strong founder effect
and genetic drift occurring during the breeding of dogs
may have significantly reduced the genetic heterogeneity
of diseases in each breed, making it easier to identify
causal mutations in dogs than in humans. Several genes
responsible for canine retinopathies have yet been identi-
fied (Table 1). We focused on PRA, a clinically homogene-
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ous group of diseases characterized by a loss of night
vision in the first few years of life (2 to 5 years). This night
blindness is followed by a progressive loss of the periph-
eral visual field and finally a total loss of vision, involving
an initial loss of rods and then cone photoreceptors [2,6].
Age-at-onset differs between breeds. PRA are also highly
heterogeneous genetically, with several modes of trans-
mission and a large number of genes and mutations
involved. Each PRA generally occurs in only one or a few
breeds, as demonstrated for PRA with a known genetic
basis [3] (Table 1). PRA-prcd is a notable exception, affect-
ing more than 20 breeds [7,8]. Only two X-linked PRA
have been described both involving the RPGR  gene
(Retinitis Pigmentosa GTPase Regulator) with a different
mutation in exon 15 (ORF15) in each breed. XLPRA1 is
caused by a deletion of five nucleotides, leading to a
frameshift and immediate premature stop in the Siberian
Husky and Samoyed. XLPRA2 is caused by a deletion of
two nucleotides leading to a frameshift that has been
shown to result in significant changes in the deduced pep-
tide sequence in a mongrel dog [9].
PRA are naturally occurring retinal diseases in dogs, and
have a phenotype similar to that of Retinitis Pigmentosa
in humans. Retinitis Pigmentosa (RP) is the most preva-
Table 1: Genes involved in canine retinopathies and in the Collie Eye anomaly, specifying the affected breeds and mutations.
Gene Chromosome Disease Affected breeds Mutation References
PDE6B
Phosphodiesterase β 
subunit
CFA3 Rod cone dysplasia
Type 1 (rcd1 et rcd1a)
Irish Setter (rcd1) Nonsense W807X [37]
Sloughi (rcd1a) 8 nucleotide insertion [38]
PDE6A
Phosphodiesterase α 
subunit
CFA4 Rod cone dysplasia
Type 3 (rcd3)
Cardigan Welsh Corgi Del A1939 [39]
RHO
Rhodopsin
CFA20 Dominant PRA English Mastiff
Bullmastiff
T4R
T4R
[40]
[41]
PDC
Phosducin
CFA7 Photoreceptors dysplasia 
(pd)
Type A-PRA
Miniature Schnauzer R82G [42]
RPGR
Retinitis Pigmentosa 
GTPase Regulator
CFA X X-Linked Progressive Retinal 
Atrophy 1 (XLPRA1)
Samoyed
Siberian Husky
Del GAGAA [9]
X-Linked Progressive Retinal 
Atrophy 2 (XLPRA2)
Mongrel Del GA [9]
CNGB3
Cyclic Nucleotide Gated 
channel β3
CFA29 Achromatopsia-3 Alaskan Malamute Deletion removing all 
exons (Del 140 kb)
[43]
German Shorthaired 
Pointer
D262N [43]
RPE65
Retinal Pigment 
Epithelium-specific protein 
65 kDa
CFA6 CSNB
Congenital stationary night 
blindness
Briard DelAAGA [44]
NHEJ1
NonHomologous End-
Joining factor1
CFA37 CEA
Collie Eye Anomaly
8 breeds (1) 7.8 kb deletion [31]
PRCD
Progressive Rod Cone 
Degeneration
CFA9 PRCD
Progressive Rod-Cone 
Degeneration
22 breeds (2) C2Y [7]
RPGRIP1
RPGR Interacting Protein 
1
CFA15 CORD1
Cone Rod Dystrophy 1
Miniature Longhaired 
Dachshund
44 nucleotide insertion [45]
BEST1
Bestrophin 1
CFA18 CMR
Canine Multi-focal 
Retinopathy
5 breeds (3) R25X
G161D
[46]
(1) Australian Shepherd, Border Collie, Lancashire Heeler, Nova Scotia DTR, Rough Collie, Shetland Sheepdog, Smooth Collie, Whippet: 
longhaired.
(2) American Cocker Spaniel, American Eskimo Dog, Australian Cattle Dog, Australian Shepherd, Australian Stumpy Tail Cattle Dog, Chesapeake 
Bay Retriever, Chinese Crested, Cockapoos, English Cocker Spaniel, Entelbucher Mountain Dog, Finnish Lapphund, Golden Retriever, Kuvasz, 
Labradoodle, Labrador Retriever, Lapponian Herder, Nova Scotia Duck Tolling Retriever, Poodle Miniature and Toy, Portuguese Water Dog, 
Spanish Water Dog, Swedish Lapphund.
(3) English Mastiff, Bullmastiff, Dogue de Bordeaux, Great Pyrenees, Coton de TulearBMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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lent group of inherited retinopathies in humans, affecting
about 1 in 3600 individuals [10]. RP display considerable
clinical and genetical heterogeneity, with wide variations
in disease onset, progression and severity [11] and several
transmission modes. Up to now, 54 loci for non-syndro-
mic RP have been mapped, for which 39 genes have been
identified [12]. Those genes account for an estimated 50%
of dominant RP, 40% of recessive RP and 80% of X-linked
RP cases [13].
Studies aiming to identify the genes responsible for X-
linked RP have led to the identification of four loci (RP6,
RP23, RP24, RP34) and only two genes (RPGR and RP2)
[14-19]. Other genes for X-linked RP remain to be identi-
fied, indeed, known genes and loci involved in those dis-
eases have been excluded in several families [20]. The
RPGR gene, a GTPase regulator that is essential for the
maintenance of photoreceptor viability, is involved in the
X-linked RP3 disease. In this gene nearly 100 mutations
have been already described in several families [21]. The
RP2 gene responsible for X-Linked RP2 disease is thought
to be involved in the beta-tubulin folding [17]. Up to 17
mutations have been identified as associated with RP2
[21]. In the last decade, the canine model has displayed
considerable genetic potential, as individual breeds corre-
spond to isolated populations, it has facilitated the iden-
tification of a number of dog genes and invaluable
candidates for the homologous diseases in humans
[22,23]. This applied to retinal diseases and PRA in partic-
ular, with the example of the identification of a new
canine gene (PRCD), responsible for PRA-prcd in different
breeds. This gene, which was not annotated in the human
genome, constituted a new candidate gene for human RP
and indeed, a mutation in this gene has been identified in
a patient from Bangladesh with RP [7].
We searched for potential candidate genes for human RP,
by investigating a PRA segregating with a high frequency
in the Border Collie breed. Three retinopathies have been
described in Border Collie: the Colley Eye Anomaly (CEA)
[24], the Central Progressive Retinal Atrophy (CPRA)
[25,26] and the (non central) Progressive Retinal Atrophy
(PRA) [27]. Border Collie belongs to the Collie lineage in
which CEA is frequently diagnosed in Colley but less fre-
quently in Border Collie. The primary clinical sign in CEA
is choroidal hypoplasia corresponding to the under-devel-
opment of the choroid. Moderately affected dogs present
a normal vision throughout life but in severely affected
individuals, colobomas at the optic nerve can lead to reti-
nal detachments and blindness [24]. CPRA has an inci-
dence of 12% in the breed in the United Kingdom, its
occurrence is between 1 and 2 years of age, with primary
brown spots in the tapetal area along the vessels, the later
stages looking like PRA. The both eyes were generally
identically affected and secondary cataract is rarer than in
PRA [25,26]. The PRA that occurs in the Border Collie has
been clinically described previously [27]. In the present
study, the clinical examination of 487 Border Collie dogs
from France demonstrated the occurrence of PRA at a high
frequency in this breed. We present a precise clinical
description of this canine PRA and the first steps of the
genetic analysis. The genetic study consisted in collecting
cases and controls as well as related individuals to investi-
gate the exact mode of transmission and to test known
canine mutations. Over 250 Border Collie blood samples
were collected, most of them could be connected through
a 375 dog pedigree. Segregation analysis suggested an X-
linked mode of transmission. We investigated the possi-
bility of the molecular cause of this PRA being a known
mutation, by carrying out the genetic tests for XLPRA1 and
XLPRA2. The exclusion of these mutations as possible
causes of the disease suggested that this PRA in Border
Collie might correspond to a new form of X-linked PRA.
We are currently collecting a larger sample of dogs for
linkage analysis.
Results
Clinical features of PRA in the Border Collie
In total, 487 dogs were examined by the same veterinary
ophthalmologist. All of them are working Border Collies
and were examined all over France, for purpose of clinical
prediction of inherited eye diseases. In total, the 241
males and 246 females were aged of 2 months to 13 years,
293 of which were at least 2 years old at the time of the
first examination (mean age at the first examination: 3.25
years); 357 dogs were examined once, 86 twice, 23 three
times, 17 four times, 4 five times, on average in the space
of a one year period.
Clinical examination consisted in the evaluation of men-
ace responses and pupillary light reflexes and indirect
ophthalmoscopic examination (30δ & 20δ lenses) after
pupillary dilatation. A total of 60 dogs (54 males, 6
females) aged between six months and nine years (mean
age of diagnostic: 3.85 year old) presented lesions of the
fundus, mostly in the tapetum: 31 dogs were bilaterally
affected, 26 dogs were unilaterally affected at the first
examination and bilaterally at the second examination
and three dogs were unilaterally affected at the second
examination and bilaterally at the third examination.
Lesions of the fundus were variable: at early stages, focal
or multifocal hyperreflective lesions of the tapetum result-
ing in thinning of the retina, with an inconstant symmetry
were frequently observed (Figure 1a), but the hyperreflec-
tive band surrounding the tapetal-nontapetal junction
was rare; at advanced stages, generalized hyperreflexion
coexisted either with hyperreflective coalescent foci in the
tapetum (Figure 1b), or with diffuse tapetal hyperreflex-
ion (Figure 1c) and depigmentation/hyperpigmentationBMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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Ophthalmoscopy; 1a: hyperreflective nasal tapetal focal lesion with a pigmented dot in a 3 years old affected male, OD: the  optic disc, the vessels and the nontapetal area are still remaining normal Figure 1
Ophthalmoscopy; 1a: hyperreflective nasal tapetal focal lesion with a pigmented dot in a 3 years old affected 
male, OD: the optic disc, the vessels and the nontapetal area are still remaining normal. 1b: Multifocal coalescent 
hyperreflective lesions in a 3,5 years old affected male: a pigmented dot is visible at the center of a suprapapillar lesion; the 
tapetum appears hyperreflective due to the coalescence of multiple focal lesions; the optic disc looks grayish and the arterial 
vasculature has disappeared. 1c: Generalized hyperreflexion of the tapetum in a 3 years old affected male, OD: the tapetum 
appears hyperreflective, with the exception of a subnormal horizontal band close to the nontapetal area; the optic disc is gray-
ish and the arteries have disappeared. 1d: OS, dog of the figure 1c: attenuation of the arterial diameter, temporal triangular 
suprapapillar hyperreflective area with a pigmented line at its center.BMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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in the nontapetum (Figure 1c and 1d), whereas the vessels
became thinner before disappearing and the optic disc
became grayish (atrophic myelin loss) (Figure 1b and 1c);
secondary cortical equatorial cataracts appeared after the
age of seven years, but this finding was rare in the affected
dogs, some of which were totally blind [28].
The correspondence between ophthalmoscopic examina-
tions and evaluation of menace responses and pupillary
light reflexes was the following:
Observations for unilateral lesions
Isolated peripheral or central hyperreflective or grayish
focal tapetal lesions, with or without a pigmented dot at
their centre: pupillary light reflexes and menace response
were present in all dogs.
Multiple hyperreflective focal lesions with diffuse
increased in tapetal reflexion, thinning of the vessels and
multifocal depigmentation of the non tapetal zone: the
menace response was present but pupillary light reflexes
were delayed and incomplete.
Observations for bilateral lesions
Isolated symmetric focal hyperreflective tapetal lesions,
with a pigmented center and focal discolored non tapetal
lesions: the menace response was present but pupillary
light reflexes were delayed and incomplete;
Symmetric horizontal hyperreflective tapetal band paral-
lel to the tapetum/non tapetum juction: the menace
response and pupillary light reflexes were present and
unmodified;
Multiple symmetric hypereflective tapetal lesions and
multifocal discolored non tapetal lesions: at reevaluation
one year later, these dogs displayed either additional sim-
ilar lesions or generalized atrophy of the fundus (coales-
cent lesions) with hyporeflective midriasis and thinning
of the vessels in all cases and palor of the papilla in some
cases; all these dogs had lost the menace response.
Electroretinography results
Electroretinography (ERG) was carried out as a comple-
mentary examination in 15 dogs (14 affected, 1 clinically
unaffected but at risk). Based on recordings in the same
conditions for a two-year-old male dog used as a refer-
ence, we found: normal traces in cases of isolated unilat-
eral peripheral or central hyperreflective or grayish
lesions; significant to severe decrease in a and b-wave
amplitude and in some cases, non recordable scotopic
blue ERGs when symmetric multifocal hyperreflective tap-
etal lesions or diffuse hyperreflective tapetum were
observed (Figure 2). A severe decrease in b-wave ampli-
tude in scotopic blue and achromatic white stimulations;
an increase in culmination phases when multiple sym-
metric hyperreflective focal lesions or diffuse hyperreflec-
tive tapetal zones were present.
Fluorescein Angiography results
Fluorescein angiography (FA) was performed in 10
affected dogs. Dogs were declared unaffected if they
remained asymptomatic after the age of five years.
Younger dogs without symptoms were considered to have
an unknown phenotype.
We observed either hypofluorescent or hyperfluorescent
defects as follows:
early focal hyperfluorescence in the tapetum by window
defect, which remained without any modification or
became wider through peripheral epithelial fluorescein
leakage throughout the angiogram (Figure 3a and 3b);
constant focal hypofluorescence linked to masking effect
by retinal pigment at the level of the lesion and progres-
sive diffusion of the fluorescein by leakage in the pigment
epithelium (Figure 3c);
linear ruptures of Bruch's membrane in the area centralis
(Figures 3c and 3d);
epithelial fluorescein leakage starting from neovessels
either in the tapetum or nontapetum and increasing dur-
ing late phases of the angiogram in advanced atrophic ret-
inal lesions (Figure 4).
All these lesions corresponded to primary retinal involve-
ment, but were not suggestive of CPRA, neither of XLPRA
1. It does not either correspond to XLPRA2 since, in
XLPRA2, retinal development is aberrant with ERG abnor-
malities at as early as 5–6 weeks of age. At the age of 4
months retinal degeneration rapidly progresses and by 2
years, retina is fully degenerated in all affected dogs [9]
whereas in the Border Collie PRA, the clinical signs are at
their beginning when observed.
Pedigree
Out of the 487 clinically examined dogs, a subset of 80
Border Collies (33 affected, 30 males and 3 females)
belonging to a large pedigree were sampled for the genetic
analysis. By retrieving the genealogical data of these 80
dogs, a pedigree of 375 individuals was constituted using
the Cyrillic 2.1 software but no common ancestor could
yet be defined (Figure 5). As previously stated, all dogs are
working Border Collies sampled from all over France and
no bias is suspected in the sampling.BMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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Segregation analysis
For inference of the genetic model best accounting for the
observed segregation of the disease in the 375-dog pedi-
gree, we performed a segregation analysis using the Gen-
eralized Linear Model approach implemented in Mendel
6.1. We chose this relatively simple segregation approach
because a highly penetrant X-linked model was suspected
in the family and because the use of Mendel6.1 made it
possible to analyze the pedigree in all its complexity. The
results are presented in Table 2. We first compared the
likelihood of the general autosomal model with that of
the X-linked model using the AIC criterion, as these two
models are not nested. The general X-linked model fitted
the data better (AICX-link = 88.4 vs AICautos = 110.6). If we
constrained the X-linked model to either a general domi-
nant (f12 = f22) or a general recessive model (f11 = f12),
the parameter estimates converged to give a fully pene-
trant recessive model with a risk allele frequency = 0.46.
The chi2 statistic for comparison of the fully penetrant X-
linked recessive model with the general X-linked model
was not statistically significant (pval = 0.10). Conse-
quently, the fully penetrant X-linked recessive model with
a risk allele frequency of 0.46 is the most parsimonious
model best fitting the data.
Mutation screening
XLPRA1 and XLPRA2
In order to check if the PRA in the Border Collie could be
due to the XLPRA1 or XLPRA2 mutations of the RPGR
gene, we tested 36 PRA affected Border Collie for XLPRA1
and 34 affected Border Collie for XLPRA2. None of those
mutations were detected in any dog.
CEA mutation
The Border Collie is one of about a dozen breeds of the
Collie lineage [29], susceptible to be affected by the Collie
Eye Anomaly (CEA) disease [30]. The frequency of this
disease depends on the breeds and the countries [24],
Electroretinograms; 2a, 2c and 2e: dark adaptation, blue light scotopic stimuli Figure 2
Electroretinograms; 2a, 2c and 2e: dark adaptation, blue light scotopic stimuli. 2b, 2d and 2f: dark adaptation, white 
light stimuli. 2a and 2b: 2 years old unaffected male. 2c and 2d: 3 years old affected male with isolated lesions. 2e and 2f: 9 years 
old affected dog with generalized lesions.BMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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Fluorescein angiograms: 3a: fundus of the figure 1a, choroidal phase: combined window effect and masking effect (arrows) Figure 3
Fluorescein angiograms: 3a: fundus of the figure 1a, choroidal phase: combined window effect and masking 
effect (arrows). 3b: fundus of the figure 1a, late venous phase: epithelial fluorescein leakage at the level of lesions. 3c: fundus 
of the figure 1d, laminar venous phase: masking effect by retinal pigment at the level of the lesion (arrow); linear leakage of flu-
orescein in the pigment epithelium (points of arrows). 3d: fundus of the figure 1d, late venous phase: most important diffusion 
of fluorescein at the periphery of the lesion; the hyperfluorescent lines (linear leakage) are corresponding to localized ruptures 
of the Bruch's membrane.BMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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being rarely detected in France, clinical signs of CEA were
found in only one dog of 1000 examined (Chaudieu, per-
sonal communication). Clinical investigations were not
suggestive of CEA in any of the dogs, but 24 dogs, includ-
ing 20 affected dogs, were nonetheless screened for the
CEA mutation in the NHEJ1 gene [31] to exclude the pos-
sible co-segregation of CEA and PRA at the molecular
level. This mutation was not detected in any of the 24
dogs tested.
PRA-prcd
The PRA-prcd mutation segregates in a large number of
breeds, indeed, it has been found in 22 breeds [7]. To
exclude the co-segregation of this mutation in Border Col-
lies, we tested 55 dogs including 34 affected dogs for the
prcd mutation in the PRCD gene [32]. This mutation was
not detected in any of the 55 dogs tested.
As no known mutations for retinopathies likely to affect
Border Collies were found in any of the dogs tested, we
suggest that the PRA segregating in this breed corresponds
to a new XLPRA (XLPRA3).
Discussion
In the present study, we described a new canine retinopa-
thy. The clinical form described here is clearly characteris-
tic of a progressive retinal atrophy (PRA): the onset of
symptoms occurred at around three years of age, and
peripheral vision was then progressively lost over the next
years. The appearance of the fundus was compatible with
PRA with distinct peripheral pigmentary changes, optic
pallor, and attenuated retinal vessels. ERG responses were
suggestive of the disease in two-year-old dogs. The pre-
dominant symptoms of night blindness, peripheral field
defects, and absence of light sensitivity strongly suggest
that this is a form of PRA [25,26].
All the clinical signs that we observed (menace responses,
pupillary light reflexes, fundus examination) were evocat-
ing a PRA:
- focal lesions were evoluting from one eye to both in
cases of unilateral lesions at the first examination;
- either focal or diffuse bilateral lesions were evolving
towards a generalized disease of he fundus in re-examined
dogs, with PRA compatible signs: tapetal hyperreflexion,
vascular attenuation, palor and enlargement of the optic
disc;
- vacuolar subcapsular equatorial cortical cataracts
observed in some dogs with severe fundic lesions were
described in other canine breeds as secondary to PRA
[6,27];
- the most important was midriasis, the most incomplete,
unstable and the slower was the pupillary light reflex, with
disappearing of the menace response in cases with severe
fundic lesions.
If only focal isolated lesions were observed, there was no
modification of the ERG. In cases of multiple or general-
ized fundic lesions, the hypovolted traces (sometimes non
recordable in blue stimulation) were in favour of a pro-
gressive rod and cone degeneration.
We never found either ophthalmoscopic, functional or
angiographic signs which correlated with CPRA: this dis-
ease was first described in several breeds, considered as
recessive autosomal in the Briard shepherd dog, domi-
nant autosomal with incomplete penetrance in the Labra-
dor Retriever, the Shetland sheepdog [25-27], dominant
autosomal with incomplete penetrance [26] or polygenic
[25] in the Border Collie. Second, it appears that environ-
mental factors were involved in CPRA: experimental Vita-
min E deficiency exactly mimicked the same fundic
lesions in the dog [33]. Nevertheless, in Border Collies,
the results of eye examination scheme in the United King-
Fluorescein angiogram; 7 years old affected male, late venous  phase: epithelial leakage of fluorescein in the tapetal area  (arrows) and in the nontapetal area (hollowed arrow), visible  choroidal vasculature (bold arrows) Figure 4
Fluorescein angiogram; 7 years old affected male, 
late venous phase: epithelial leakage of fluorescein in 
the tapetal area (arrows) and in the nontapetal area 
(hollowed arrow), visible choroidal vasculature (bold 
arrows).BMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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dom remained in favor of an hereditary origin: in 1965,
12% of the dogs were affected of CPRA; in 1989, only 2%
were exhibiting ophthalmoscopic changes characteristic
of the disease [25,26]. All the findings of FA were demon-
strating that the primary changes in the fundus were not
related to a pigment epithelium dystrophy: we never
found the specific lesions of fluorescence mottled mask-
ing by lipofuscinic like pigment deposits [34]. We showed
that this PRA segregates according to an X-linked mode of
transmission. This is compatible with the status of the few
affected females identified. Indeed, the six females found
affected, after clinical examination, were diagnosed
between 18 months and 3 years old and clinical symp-
toms were very similar to those observed in males. More-
over, all females presented similar clinical features. For
three of them, we do not have any genealogical data and
thus we do not know the status of the parents. For the
other three affected females, which are in the pedigree,
they were all born from an affected father and an obligate
carrier female. Considering the high level of inbreeding in
the breed, we assume that affected females come from
obligate carriers and affected males, supporting a fully
penetrant recessive inheritance mode. Genetic tests car-
ried out on subsets of dogs excluded the involvement of
known mutations.
We excluded the XLPRA1 and XLPRA2 mutations as the
possible causal mutation for this X-linked PRA. However,
owing to differences in the clinical signs and age-of-onset
observed with XLPRA2, the second ORF15 mutation in
RPGR could likely be excluded [9]. The CEA mutation is
frequent in the Collie lineage, but occurs at only low fre-
quency in the Border Collie breed in France (Chaudieu,
personal communication). We nonetheless tested for the
presence of the CEA mutation that could co-segregate. As
expected, the dogs analyzed did not carry the mutation,
consistent with the low prevalence of CEA in the Border
Collie. Finally, we also tested for the presence of the muta-
Illustration of a Border Collie pedigree segregating PRA constructed by the Cyrillic 2.1 software Figure 5
Illustration of a Border Collie pedigree segregating PRA constructed by the Cyrillic 2.1 software. This pedi-
gree is constituted of 80 dogs, 33 dogs are affected (30 males and 3 females).
A
SBMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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tion for PRCD, which has been involved in many dog
breeds displaying PRA-prcd, while these breeds have no
evident common origin [7]. Neither CEA, nor prcd were
found to co-segregate in affected Border Collies.
In human, retinitis pigmentosa occurs and presents clini-
cal features similar to canine PRA. Human cases experi-
ence a decrease in peripheral and night vision in their
twenties, then night blindness and diminution of the vis-
ual field in their thirties, but visual acuity and color vision
may remain normal until advanced stages of the disease
[13]. Clinically, X-linked RP are the most severe forms of
RP [13] but only 2 genes have yet been identified on the X
chromosome. Human families are often too small for the
identification of the causal loci by linkage studies and
families cannot be grouped for genetic linkage analyses
because of possible genetic heterogeneity. Indeed, several
causal genes have already been identified in inbred fami-
lies [12]. As dog pedigrees are highly inbred, it may be a
useful model to identify new candidate genes for X linked
RP.
The pedigree used for the segregation analysis is currently
being completed for genetic linkage analysis to search for
the genetic locus involved in the disease. The XLPRA1 and
XLPRA2 mutations are not involved in this XLPRA, but we
cannot exclude the involvement of other mutation in the
RPGR  gene. Indeed, this is the only gene involved in
canine XLPRA with two mutations presently described in
exon 15. In human, RPGR is frequently and differently
mutated in XLRP. Other human candidates, such as the
XLRP gene (RP2) or loci (RP6, 23, 24, 34) [14-19] may be
analysed. We expect linkage analysis to be more efficient
to test the involvement of genes and loci, as gene sequenc-
ing cannot unequivocally exclude the involvement of a
gene if no mutation is found especially as some regions
are usually unscreened, such as introns, 5' and 3' UTR or
other regulatory regions.
Conclusion
Studies of this new XLPRA should lead to the identifica-
tion of a new mutation in one of the previously identified
genes or in a new gene on the X chromosome in dog. This
disease could constitute a model for X-linked human RP.
As 20% of XLRP genes remain to be identified in human
[13], the Border Collie provides an opportunity to identify
a new causal gene thus representing a potentially perti-
nent model for studying the genetic bases of XLRP in
human.
Methods
All experiments have been performed under agreement
reference number A35-238-13 delivered in July 2003 by
the animal healthcare and protection service of the French
government.
Clinical investigation/ophthalmologic examination
None of the dogs was kept for research purposes. All were
privately owned sheep dogs.
The 487 dogs were examined both by evaluating pupillary
light reflexes and menace response and by indirect oph-
thalmoscopy (30δ & 20δ lenses) after pupillary dilation
(0.5% Tropicamide drops, Mydriaticum®, Théa, Cler-
mont-Ferrand Cedex, France).
Electroretinography (ERG)
ERG included the following procedures: pupillary dilata-
tion (Mydriaticum®); dark adaptation for 15 min; general
anesthetic (2% xylazine, Rompun®, Bayer Pharma,
Puteaux cedex – France: 0,05 mL/kg and 10% ketamine
chlorhydrate, Imalgene 1000®, Merial, Lyon – France: 0,05
mL/kg) administered IV; 10 achromatic stimulations for
each eye with a white standard flash (2,5 cd/s/m2), at a 1
Hz frequency; 10 chromatic stimulations for each eye with
a blue filter (440 nm) at a scotopic level and a 1 Hz fre-
quency; signals recorded with needle electrodes (active
and reference electrodes for each eye).
Fluorescein Angiography (FA)
FA was performed without sedation after pupillary dilata-
tion (Mydriaticum®) using a Kowa – RC fundus camera
(Kowa Company, Tokyo, Japan) fitted with a specially
adapted blue stimulation blue filter, yellow filters and
loaded with Ilford HP5 ISO 400 black-and-white film
(Ilford Imaging, Mobberley, UK); 10% Sodium fluores-
ceinate (2 mL/10 kg bodyweight, Ciba Vision Ophthal-
Table 2: Segregation analysis – Parameter estimates, log-
likelihood and AIC associated with the general autosomal mode 
of transmission and the general, dominant and recessive X-
linked modes of transmission.
Autosomal X-linked
General General Dominant Recessive
q2 0.39 0.39 0.54 0.46
f11 0.38 0.29 1 0
f12 0.31 0 0 = f11
f22 0.41 0.88 = f12 1
No. 43 11
-2 lnL 102.6 82.4 87 87
AIC 110.6 88.4 89 89
χ2(df) 4.6(2) 4.6(2)
P 0.10 0.10
q2: frequency of the risk allele 2; f11, f12, f22: penetrances of genotypes 
11, 12 and 22. No.: No. of independent parameters estimated = (no. 
of parameters in the model)-(no. of parameters that converged to a 
boundary); lnL: log-likelihood; AIC: Aikaike criterion (-2 lnL + 2 No). 
χ2 (df): chi-squared test comparing the general X-linked model with 
the restricted X-linked models. P: associated p-value.BMC Veterinary Research 2008, 4:10 http://www.biomedcentral.com/1746-6148/4/10
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mics, Toulouse – France) was injected intravenously,
when starting the examination of the fundus.
Pedigree analysis
A 375-dog multigeneration pedigree, connecting 87 dogs
with known phenotypes was constructed. 33 dogs are
affected (30 males and 3 females). This pedigree is highly
inbred with frequent marriage loops. We used the Cyrillic
software v2.1 [35] (© CyrillicSoftware) for genealogic and
genetic data management.
All dogs subjected to genetic analysis for which parental
DNA was available, were tested for parental compatibility
using the ISAG reference markers.
Genomic DNA extraction
Blood samples and the accompanying pedigree were col-
lected by DVM veterinaries or based on information
obtained directly from the owners. All data were entered
into a database. Genomic DNA was extracted from 5 ml of
blood collected into EDTA, using the nucleon BACC 3 kit
(GE Healthcare Bio-Sciences Corp, Piscataway, NJ, USA).
The extracted DNA was "Whole Genome Amplified" using
the V1 Genomiphi kit (GE Healthcare).
Segregation analysis
Segregation analysis was performed on a 375-dog pedi-
gree, that corresponds partially to the diagnosed dogs,
using the generalized linear model-based approach
implemented in Mendel 6.1 [36]. We analyzed the quali-
tative phenotype under study, by considering the logit
function as a link function in the model. Briefly, let p be
the probability of being affected, conditional on the gen-
otype and let X11, X12, X22 be binary variables describing
the genotype at a biallelic disease locus (X11 = 1 and X12 =
X22  = 0 for genotype 11). The general model is
. The different seg-
regation models to be compared in the analysis are
expressed as constraints on (β1, β2, β3). Likelihoods of the
models are compared with likelihood ratio statistics when
models are nested and using the AIC criterion (best model
minimizes (-2 lnL + 2 No), where L is the Likelihood of
the model and No the number of independent parameters
estimated in the model) for non nested models.
Mutation testing
Dogs of the pedigree were screened for the known muta-
tions, XLPRA1 [9], prcd [7,32] and the mutation for Col-
ley Eye Anomaly (CEA) [31] as described. For the XLPRA2
mutation, primers were designed using the RPGR ORF15
sequence (AF385629) [9]. The PCR were performed with
DNA amplified by Genomiphi V2 (GE Healthcare).
Primers:
For XLPRA1 mutation [9]:
RGF14: AAGGGGAGGAGAAAGGGGAGGCT
RGR13: TCCCTCTTCCTCCTCCCCTTCATA
For XLPRA2 mutation:
XLPRA2U: AGAGGCAGAATGGGAAGGAA
XLPRA2L: CCGTCTTCCCTGTTTTTCAC
For CEA mutation [31]:
aF-D GGAGGAGTCATCATGACTTGC
aR-D GACTGGTATTATCAAAGGTCAC
For PRA-prcd mutation [32]:
prcd1f: CCAGTGGCAGCAGGAACC
prcd2r: CCGACCTGCTGCCCACGACTG
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